| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.3M | -88.0% |
| Cost of Revenue | $2.4M | -28.8% |
| R&D Expense | $455.7M | +14.1% |
| SG&A Expense | $150.6M | +5.2% |
| Operating Income | -$607.4M | -18.6% |
| Interest Expense | $81.3M | +1.1% |
| Net Income | -$653.3M | -34.8% |
| EPS (Basic) | -$3.95 | -21.2% |
| EPS (Diluted) | -$3.95 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $375.9M | -0.2% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $477.6M | -13.0% |
| Total Assets | $546.4M | -12.3% |
| Current Liabilities | $143.8M | +18.5% |
| Long-term Debt | $446.4M | +3.6% |
| Total Liabilities | $1.89B | +1.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$527.7M | -25.8% |
| Capital Expenditures | $1.3M | -72.9% |
| Investing Cash Flow | $54.0M | -88.1% |
| Financing Cash Flow | $451.5M | +3537.9% |
| Free Cash Flow | -$529.0M | -24.7% |
| -21.2% |
| Stockholders' Equity |
| -$1.35B |
| -7.9% |